Skip to contentE
Electromedical Technologies, Inc
E
EMEDElectromedical Technologies, Inc Q2 2023 · 10-Q
Revenue$294.95K$294.95K+30.9% vs Q2 2022 Net Income-$1.46M-$1.46MN/M vs Q2 2022 EPS Diluted$0.00$0.00— vs Q2 2022 Gross Profit$232,435+29.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Electromedical Technologies, Inc · CIK 1715819 · Engraved from SEC EDGAR
Operating Cash Flowderived-$635,930N/M Margins · derivedGross margin78.8%−1.1 pt vs Q2 2022
Operating margin-115.7%+10.0 pt vs Q2 2022
Net margin-494.9%−257.0 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 21, 2023 · 52 d after period end